1. X
  2. Aakash Desai, MD, MPH, FASCO
Log inSign up
Aakash Desai, MD, MPH, FASCO
9,791 posts
Image
user avatar
Aakash Desai, MD, MPH, FASCO
@ADesaiMD
Thoracic/Phase 1 Oncologist @ONealCancerUAB, Asst Prof @UABMedicine | Alum @MayoHemeOnc @UConnIM @MDAndersonNews| Co-Host @HemOncFellows πŸŽ™οΈ @LungCancerRX
Birmingham, AL
bit.ly/45RWj88
Joined June 2019
1,562
Following
6,739
Followers
RepliesRepliesMediaMedia

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

TermsΒ·PrivacyΒ·CookiesΒ·AccessibilityΒ·Ads InfoΒ·Β© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • Pinned
    user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    Jul 4, 2020
    As #oncologytrainees prepare for their first #patientencounter, the #SPIKES protocol is often a good starting point. What advise do you have for #trainees when #deliveringbadnews? @marklewismd @NarjustDumaMD @GlopesMd @mtmdphd @VPrasadMDMPH @DevikaDasMD @MayoHemeOnc #HOFellowLife
    Image
  • user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    May 30, 2024
    🚨T-1 #ASCO24 @ASCO! πŸ’ͺ🏼 All set to showcase exciting #NSCLC #LCSM research! #ASCOLung24 ⬇️ Current updated management algorithm for NSCLC, with addition of 1️⃣ Periop Pembrolizumab 2️⃣ Adjuvant Alectinib 3️⃣ Osi/Chemo for EGFRm 4️⃣ Ami/Chemo for EGFR Ex20ins 5️⃣ Repotrectenib ROS1
    Image
    Image
    66K066K
  • user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    Feb 9, 2023
    As @HemOncFellows , #bcsm management has become increasingly complex! Below is a #study guide for #MedOnc #MedEd fellows I have been working on : What do you think? 🧐 @IlanaSchlam @PTarantinoMD @OncBrothers @rleonferre πŸ›‘ #WorkinProgress #NotMedicalAdvice πŸ™ #InputsWelcome
    Image
    72K072K
  • user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    Feb 21, 2023
    Excited for @IASLC #TTLC23 #TTLC2023 to hear the latest on 🫁 #LCSM! @HemOncFellows, prepare for the meeting with #studyguide for #NSCLC treatment! ⬇️ #clinicaltrials are imp to consider! #NotMedicalAdvice #InputsWelcome πŸ™ @OncoAlert @MayoHemeOnc @MatthewHoMD @OncMedEdCoP
    Image
    64K064K
  • user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    May 30, 2023
    Thrilled to announce my next adventure as a Thoracic/Phase 1 Medical Oncologist with @ONealCancerUAB! Heartfelt gratitude for the support of my family, colleagues, and mentors. πŸ™πŸ»πŸ™πŸ» Y’all! Let’s connect at @ASCO #ASCO23 to discuss partnerships, collaborations and trials in
    Image
    37K037K
  • user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    Dec 5, 2022
    πŸŽ„πŸŽ… arrived early this year, thanks to @MayoClinic @MayoCancerCare! Honored and grateful to be conferred the rank of β€œAssistant Professor of #Medicine” @MayoClinic πŸ“œ ! Thank you to all who believed in me! @MayoHemeOnc πŸ™πŸ»πŸ™πŸ»
    Image
  • user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    May 27, 2022
    Replying to @ADesaiMD
    Step 1⃣, let's review what we know already! πŸ‘‡ #algorithm created with @MatthewHoMD giving πŸ”into current Rx, credit @NCCN @JackWestMD PDF: bit.ly/3yZIm7P, blue text πŸ‘‰ hyperlinks to the trials for πŸ’ŠπŸ’‰ Hoping this isπŸ“–πŸ”–resource for #patients, and #providers @OncoAlert
    Image
  • user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    Feb 14, 2023
    Are you looking forward to the exciting data being presented @ASCO #GU23! πŸ“ˆ Prepare yourself πŸ“š with this study guide on #RCC #renalcellcancer #kidneycancer before #GU23! #InputsWelcome #NotMedicalAdvice @OncoAlert @shilpaonc @neerajaiims @crisbergerot @montypal
    Image
    41K041K
  • user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    May 31, 2022
    #ASCO22 Small Cell Lung CancerπŸ“°πŸ§΅ 1⃣st review what we know already! πŸ‘‡ #algorithm created with @MatthewHoMD for #SCLC Rx, credit: @NCCN @JackWestMD PDF: bit.ly/3GxPCJI, blue text πŸ‘‰ hyperlinks to trials forπŸ’ŠπŸ’‰ AnotherπŸ”–resource for #patients/#providers @OncoAlert
    Image
    user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    May 27, 2022
    #ASCO22 Abstracts released today! Let's dig into some #LCSM studies of interest, trying to create 🧡here and πŸ‘€ for #pre-@ASCO discussion! @OncBrothers @OncoAlert @StephenVLiu @JackWestMD @n8pennell @FordePatrick @AMansfieldMD @LaurenByersMD, hoping to meet #LCSM experts #IRL!
  • user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    Jun 2, 2024
    LAURA Ph 3: Osimertinib vs Placebo #ASCO24 @ASCO ➑️ mPFS: 39.1 vs 5.6 mo (HR 0.16) ‼️ ➑️ 24-mo PFS: 65% vs 13% πŸ“ˆ ➑️ 81% received osi at progression πŸ’Š, Good! ➑️AE discontinuation**: 13% vs 5% ⚠️ Can't wait for @RamalingamMD's presentation today! 🎀 #ASCO24 @OncoAlert Data
    Image
    28K028K
  • user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    May 23, 2020
    Feeling bad about not being able to travel to #ASCO20? Maybe this will help! Travel in the time of #COVID19! @ASCO x.com/alvinfoo/statu…
  • user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    Aug 29, 2022
    #ESMO22 @myESMO is πŸ”œ, so let’s review where we were @ASCO #ASCO22 in #LCSM to prepare ourselves! We (@FawziAbuRous @esinghimd @msalmanfaisal @drRTee) review major β€œ#Lung #Cancer Treatment Advances ⏩ in 2022” in #CancerInvestigation @HemOncFellows @OncoAlert @LUNGevity @IASLC
    Image
  • user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    Mar 12, 2024
    It’s official πŸŽ‰ My first #grant as faculty and PI few months into my first year on faculty! πŸ™ Could not have asked for more! @ONealCancerUAB @lcrf_org Thank you to all my mentors and colleagues who brought me here! @HemOncFellows @LungCancerRx @MayoHemeOnc @IMG_Oncologists
    user avatar
    Lung Cancer Research Foundation
    @lcrf_org
    Mar 12, 2024
    LCRF has announced 3 research grant awards funded by Daiichi Sankyo and AstraZeneca, focused on further developing the understanding of the proposed mechanism of action of antibody drug conjugates (ADCs). LCRF.org/ADC #LungCancer @ADesaiMD @NSethakorn Carl Gay, MD, PhD
    Image
    17K017K
  • user avatar
    Aakash Desai, MD, MPH, FASCO
    @ADesaiMD
    Mar 10, 2021
    "#Antigen #presentation in #cancer: insights into tumour immunogenicity and immune evasion" @NatureRevCancer go.nature.com/3l36hu8 Jhunjhunwala et al. describe mechanisms of immune evasion by alteration of antigen repertoire presented on tumors @OncoAlert
    Image
    Image
    Image
    Image
Advertisement
Advertisement